Bulário Digital
For healthcare professionals and citizens seeking informational access to Brazilian medication documentation.
Overview · Full Intel report in progress
Bulário Digital is an established medical app that is a paid app. With a 3.7/5 rating from 38 reviews, it shows polarized user reception.
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Provides access to 7,288 leaflets for commercial medications available in Brazil.
Allows users to search by commercial name, substance, laboratory, or specific keywords within the leaflet content.
Includes a dynamic filter that narrows results as the user types the search query.
Enables users to save specific medication leaflets for quick future reference.
How much does it cost?
Who Built It?
F&E System Apps
Providing offline digital reference tools and digitized foundational texts for legal professionals, medical practitioners, and students of philosophy.
Portfolio
13
Apps
What other apps does F&E System Apps make?
Explore the full F&E System Apps report
Portfolio breakdown, audience, momentum, and every app published by F&E System Apps.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Bulário Digital?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
1 active ranking tracked — 30-day window
Which niche is Bulário Digital in?
to access medication leaflets and usage information
Explore the full Pharmaceutical Information Readers niche
Every app in this space — 1 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Bulário Digital
Key Takeaways
This is a static, informational reference tool for Brazilian medication data that explicitly warns against using its content for self-medication.
Where Is It Heading?
Trend analysis
Available very soon